Skip to main content
https://pbs.twimg.com/media/F-wMHQ5WwAArfoJ.png
YR in Review: Dr. P Seo ⭐️Sarilumab for relapse of PMR during GC taper: ➡️ab against IL6R ➡️118 pts: ⏺️pred 15 mg/d ⏺️Sari 200 mg/d q2wk/14wk ⏺️52wk pred taper ➡️At wk 52: ⏺️sustained remission: 28% vs 10% ⏺️mean total GC: 777 vs 2044 mg #ACR23 @RheumNow https://t.co/ETVpyuBlZ7
Meral K. El Ramahi, MD
12-11-2023
×